These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Analysis of the repertoire of anti-idiotypic B-cell responses to self-I-Ak- or -I-Ek-reactive monoclonal antibodies in A.TL mice.
    Author: Devaux C, Pierres M.
    Journal: Scand J Immunol; 1983 Apr; 17(4):375-87. PubMed ID: 6601297.
    Abstract:
    Twenty anti-idiotypic antisera (anti-Ids) were produced in A.TL mice to self-I-Ak or -I-Ek-reactive monoclonal antibodies (mAbs), constructed in the A.TH anti-A.TL combination. The reactivity of these anti-Ids was examined in a panel of 31 anti-Iak A.TH mAbs, using direct idiotype binding, cross-competitive inhibition of idiotype binding, and isoelectrofocusing (IEF) assays. Among 13 anti-Ids produced against anti-I-Ak mAbs, one only recognized individual idiotypic specificities (IdIs) on its corresponding mAb, while the 12 others identified homologous IdIs and recurrent idiotypic specificities also expressed on heterologous anti-I-Ak and/or I-Ek mAbs. Two sets of major cross-reactive idiotypes (IdXs) were characterized on two groups of mAbs recognizing public Ia.1, I-Ak,f,u and r) or private (Ia.2, I-Ak) determinants clustered in two spatially distinct epitope regions of the I-Ak molecule, respectively. By contrast, most (5/7) of the anti-Ids raised against mAbs recognizing polymorphic or monomorphic (Ia.7-like) I-Ek determinants displayed specificity apparently restricted to their corresponding mAb IdIs. This finding contrasted with the previous characterization, using xenogeneic anti-idiotypic reagents, of an interstrain IdX expressed on all mAbs defining Ia.7-like determinants in the IEk epitope group I. These data indicate that A.TL mice can readily develop anti-idiotypic responses towards self Ia-reactive mAb minor idiotypes (IdIs) and that recognition of anti-Iak mAb IdXs in such mice is preferentially observed when anti-I-Ak mAbs are used as immunogens.
    [Abstract] [Full Text] [Related] [New Search]